Cargando…
Radiosensitization of Glioma Cells by Temozolomide (TMZ): A Colony Formation Assay
BACKGROUND: Glioblastoma is one of the most radioresistant cancers. It is suggested that combination of radiotherapy with other cancer treatment modalities may increase control of tumor. Temozolomide (TMZ) is one of the most known drugs for glioblastoma. It has shown that TMZ via induction of mutati...
Autores principales: | Babaloui, Somayyeh, Najafi, Masoud, Mozdarani, Hossein, Borhani, Samira, Jaberi, Ramin, Aghili, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819262/ https://www.ncbi.nlm.nih.gov/pubmed/35155292 http://dx.doi.org/10.31661/jbpe.v0i0.1223 |
Ejemplares similares
-
In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme
por: Borhani, Samira, et al.
Publicado: (2017) -
TMZ-BioShuttle – a reformulated Temozolomide
por: Waldeck, Waldemar, et al.
Publicado: (2008) -
Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy
por: Zong, Zhenkun, et al.
Publicado: (2019) -
OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth()()
por: Towner, Rheal A., et al.
Publicado: (2018) -
Adjuvant high-dose-rate brachytherapy in the management of oral cavity cancers: 5 years of experience in Iran
por: Kazemian, Ali, et al.
Publicado: (2017)